Jason Pan

Medicine & Life Sciences

1. Fibrosis 100%
2. Induced Pluripotent Stem Cells 97%
3. Elasticity Imaging Techniques 96%
4. Liver Diseases 83%
5. Fatty Liver 80%
6. Zinc Finger Nucleases 66%
7. Yttrium-90 64%
8. Sustained Virologic Response 58%
9. Chronic Granulomatous Disease 58%
10. Liver Cirrhosis 56%
11. Myocardial Perfusion Imaging 53%
12. Liver Transplantation 52%
13. Cholangitis 52%
14. Cholangiocarcinoma 49%
15. Blood Volume 44%
16. Hepatitis C 44%
17. Transgenes 43%
18. Positron-Emission Tomography 40%
19. Oxidoreductases 39%
20. Antiviral Agents 37%
21. Liver 36%
22. Neutrophils 33%
23. Liver Neoplasms 32%
24. Xanthogranulomatous cholecystitis 30%
25. Non-alcoholic Fatty Liver Disease 27%
26. Neoplasm Metastasis 26%
27. Hematopoietic Stem Cells 24%
28. Reactive Oxygen Species 20%
29. Gene Targeting 20%
30. Population 16%
31. Biopsy 13%
32. Hepatitis 13%
33. Body Mass Index 13%
34. 4-ethoxymethylene-2-phenyl-2-oxazoline-5-one 12%
35. Autoimmune Diseases 12%
36. Waist-Height Ratio 12%
37. Virus Integration 11%
38. Blood Pressure 11%
39. Alcohols 10%
40. Monocytes 10%
41. Insertional Mutagenesis 10%
42. Clone Cells 9%
43. Nutrition Surveys 9%
44. Therapeutics 8%
45. Regression Analysis 8%
46. Neoplasms 8%
47. Smoking 8%
48. Alanine Transaminase 8%
49. Stroke Volume 8%
50. ROC Curve 8%